Glucose Homeostasis in Relation to Neutrophil Mobilization in Smokers with COPD

References

• The top 10 cases of death, World Health Organization. 2020; Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 23 December, 2021.
   Google Scholar
• Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009;4:435–459.
   PubMed Web of Science ®Google Scholar
• Miller J, Edwards LD, Agusti A, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013;107(9):1376–1384.
   PubMed Web of Science ®Google Scholar
• American Diabetes A. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–S27.
   PubMed Web of Science ®Google Scholar
• Spranger J, Kroke A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 2003;52(3):812–817.
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome. Circulation. 2009;120(16):1640–1645.
   PubMed Web of Science ®Google Scholar
• Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004;110(4):380–385.
   PubMed Web of Science ®Google Scholar
• Ehrlich SF, Quesenberry CP, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care. 2010;33(1):55–60.
   PubMed Web of Science ®Google Scholar
• Hughes MJ, McGettrick HM, Sapey E. Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target. Eur Respir Rev. 2020;29:155.
   Web of Science ®Google Scholar
• Piazzolla G, Castrovilli A, Liotino V, et al. Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): the interplay among smoking, insulin resistance and vitamin D. PLoS One. 2017;12(10):e0186708.
   PubMed Web of Science ®Google Scholar
• Hoenderdos K, Condliffe A. The neutrophil in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2013;48(5):531–539.
   PubMed Web of Science ®Google Scholar
• O’Donnell RA, Peebles C, Ward JA, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax. 2004;59(10):837–842.
   PubMed Web of Science ®Google Scholar
• Andelid K, Andersson A, Yoshihara S, et al. Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1253–1263.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang Z, Zhang W, et al. White blood cell subtypes and risk of type 2 diabetes. J Diabetes Complications. 2017;31(1):31–37.
   PubMed Web of Science ®Google Scholar
• Buyukkaya E, Karakas MF, Karakas E, et al. Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost. 2014;20(2):159–163.
   PubMed Web of Science ®Google Scholar
• Liew PX, Kubes P. The neutrophil’s role during health and disease. Physiol Rev. 2019;99(2):1223–1248.
   PubMed Web of Science ®Google Scholar
• McDonald B, Kubes P. Innate immune cell trafficking and function during sterile inflammation of the liver. Gastroenterology. 2016;151(6):1087–1095.
   PubMed Web of Science ®Google Scholar
• Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med. 2011;17(11):1381–1390.
   PubMed Web of Science ®Google Scholar
• Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL, Silliman CC. Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res. 1998;76(1):91–94.
   PubMed Web of Science ®Google Scholar
• Zeilhofer HU, Schorr W. Role of interleukin-8 in neutrophil signaling. Curr Opin Hematol. 2000;7(3):178–182.
   PubMed Web of Science ®Google Scholar
• Williams JG, Jurkovich GJ, Maier RV. Interferon-gamma: a key immunoregulatory lymphokine. J Surg Res. 1993;54(1):79–93.
   PubMed Web of Science ®Google Scholar
• Pham CT. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol. 2006;6(7):541–550.
   PubMed Web of Science ®Google Scholar
• Henry CM, Sullivan GP, Clancy DM, Afonina IS, Kulms D, Martin SJ. Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines. Cell Rep. 2016;14(4):708–722.
   PubMed Web of Science ®Google Scholar
• Bolton CE, Evans M, Ionescu AA, et al. Insulin resistance and inflammation - a further systemic complication of COPD. COPD. 2007;4(2):121–126.
   PubMedGoogle Scholar
• Di Stefano A, Coccini T, Roda E, et al. Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema. Int J Chron Obstruct Pulmon Dis. 2018;13:1691–1700.
   PubMed Web of Science ®Google Scholar
• Cimini FA, Barchetta I, Porzia A, et al. Circulating IL-8 levels are increased in patients with type 2 diabetes and associated with worse inflammatory and cardiometabolic profile. Acta Diabetol. 2017;54(10):961–967.
   PubMed Web of Science ®Google Scholar
• Shin MJ, Lee KH, Chung JH, et al. Circulating IL-8 levels in heart failure patients with and without metabolic syndrome. Clin Chim Acta. 2009;405(1–2):139–142.
   PubMed Web of Science ®Google Scholar
• Kovach MA, Che K, Brundin B, et al. IL-36 cytokines promote inflammation in the lungs of long-term smokers. Am J Respir Cell Mol Biol. 2021;64(2):173–182.
   PubMed Web of Science ®Google Scholar
• Bassoy EY, Towne JE, Gabay C. Regulation and function of interleukin-36 cytokines. Immunol Rev. 2018;281(1):169–178.
   PubMed Web of Science ®Google Scholar
• Sims JE, Smith DE, The IL-1. family: regulators of immunity. Nat Rev Immunol. 2010;10(2):89–102.
   PubMed Web of Science ®Google Scholar
• Elias M, Zhao S, Le HT, et al. IL-36 in chronic inflammation and fibrosis - bridging the gap? J Clin Invest. 2021;131:2.
   Web of Science ®Google Scholar
• Ramadas RA, Ewart SL, Medoff BD, LeVine AM. Interleukin-1 family member 9 stimulates chemokine production and neutrophil influx in mouse lungs. Am J Respir Cell Mol Biol. 2011;44(2):134–145.
   PubMed Web of Science ®Google Scholar
• Ramadas RA, Ewart SL, Iwakura Y, Medoff BD, LeVine AM. IL-36alpha exerts pro-inflammatory effects in the lungs of mice. PLoS One. 2012;7(9):e45784.
   PubMed Web of Science ®Google Scholar
• Giannoudaki E, Hernandez-Santana YE, Mulfaul K, et al. Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction. Nat Commun. 2019;10(1):4003.
   PubMed Web of Science ®Google Scholar
• Liu M, Guo S, Hibbert JM, et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011;22(3):121–130.
   PubMed Web of Science ®Google Scholar
• Cassatella MA, Gasperini S, Calzetti F, Bertagnin A, Luster AD, McDonald PP. Regulated production of the interferon-gamma-inducible protein-10 (IP-10) chemokine by human neutrophils. Eur J Immunol. 1997;27(1):111–115.
   PubMed Web of Science ®Google Scholar
• Tangedal S, Nielsen R, Aanerud M, et al. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. PLoS One. 2019;14(9):e0222449.
   PubMed Web of Science ®Google Scholar
• Chang CC, Wu CL, Su WW, et al. Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease. Sci Rep. 2015;5:10096.
   PubMed Web of Science ®Google Scholar
• Padra M, Andersson A, Levanen B, et al. Increased MUC1 plus a larger quantity and complex size for MUC5AC in the peripheral airway lumen of long-term tobacco smokers. Clin Sci (Lond). 2020;134(10):1107–1125.
   PubMed Web of Science ®Google Scholar
• Stockfelt M, Christenson K, Andersson A, et al. Increased CD11b and Decreased CD62L in Blood and Airway Neutrophils from Long-Term Smokers with and without COPD. J Innate Immun. 2020;1:1–10.
   Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5–40.
   PubMedGoogle Scholar
• Salorinne Y. Single-breath pulmonary diffusing capacity. Reference values and application in connective tissue diseases and in various lung diseases. Scand J Respir Dis Suppl. 1976;96:1–84.
   PubMedGoogle Scholar
• Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet. 1965;1:775–779.
   PubMedGoogle Scholar
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
   PubMed Web of Science ®Google Scholar
• Kovach MA, Singer B, Martinez-Colon G, et al. IL-36gamma is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia. Mucosal Immunol. 2017;10(5):1320–1334.
   PubMed Web of Science ®Google Scholar
• Kovach MA, Singer BH, Newstead MW, et al. IL-36gamma is secreted in microparticles and exosomes by lung macrophages in response to bacteria and bacterial components. J Leukoc Biol. 2016;100(2):413–421.
   PubMed Web of Science ®Google Scholar
• Smith ME, Bozinovski S, Malmhäll C, et al. Increase in net activity of serine proteinases but not gelatinases after local endotoxin exposure in the peripheral airways of healthy subjects. PLoS One. 2013;8(9):45.
   Web of Science ®Google Scholar
• Kao CC, Hsu JW, Bandi V, Hanania NA, Kheradmand F, Jahoor F. Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease. J Appl Physiol. 2012;112(1):42–47.
   PubMed Web of Science ®Google Scholar
• Creutzberg EC, Schols AM, Bothmer-Quaedvlieg FC, Wouters EF. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr. 1998;52(6):396–401.
   PubMed Web of Science ®Google Scholar
• Liu HY, Collins QF, Moukdar F, et al. Suppression of hepatic glucose production by human neutrophil alpha-defensins through a signaling pathway distinct from insulin. J Biol Chem. 2008;283(18):12056–12063.
   PubMed Web of Science ®Google Scholar
• Palomino DC, Marti LC. Chemokines and immunity. Einstein. 2015;13(3):469–473.
   PubMed Web of Science ®Google Scholar
• Saetta M, Mariani M, Panina-Bordignon P, et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;165(10):1404–1409.
   PubMed Web of Science ®Google Scholar
• Michalec L, Choudhury BK, Postlethwait E, et al. CCL7 and CXCL10 orchestrate oxidative stress-induced neutrophilic lung inflammation. J Immunol. 2002;168(2):846–852.
   PubMed Web of Science ®Google Scholar
• Herder C, Baumert J, Thorand B, et al. Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia. 2006;49(5):921–929.
   PubMed Web of Science ®Google Scholar
• Punthakee Z, Goldenberg R, Katz P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Canadian J Diabetes. 2018;42:S10–S15.
   PubMed Web of Science ®Google Scholar
• Stanescu D, Sanna A, Veriter C, et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax. 1996;51(3):267–271.
   PubMed Web of Science ®Google Scholar
• von Scheele I, Larsson K, Dahlen B, et al. Toll-like receptor expression in smokers with and without COPD. Respir Med. 2011;105(8):1222–1230.
   PubMed Web of Science ®Google Scholar
• Barisione G, Baroffio M, Crimi E, Brusasco V. Beta-Adrenergic Agonists. Pharmaceuticals. 2010;3(4):1016–1044.
   Google Scholar
• Philipson LH. beta-Agonists and metabolism. J Allergy Clin Immunol. 2002;110(6 Suppl):S313–317.
   PubMedGoogle Scholar